{"status":"OK","data":{"advertisement":{"id":200390,"title":"Zapytanie ofertowe 31 03 2023 IMP","partial_offer_allowed":false,"publication_date":"2023-03-31","submission_deadline":"2023-05-02 23:59:59","planned_sign_date":"2023-05-01","supplementary_orders":"Zgodnie z tre\u015bci\u0105 za\u0142\u0105czonego zapytania ofertowego (.pdf)","terms_of_contract_change":"Zgodnie z tre\u015bci\u0105 za\u0142\u0105czonego zapytania ofertowego (.pdf)","created_at":"2023-03-31 13:19:49","modified_at":"2023-05-03 00:00:03","contact_persons":[{"id":57,"forename":"Aleksandra","surname":"Mazga\u0142a","phone_number":"+48 538 899 945","email":"tenders@ryvu.com","created_by":null,"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":null},{"id":58,"forename":"Anna","surname":"Dziedzicka","phone_number":"+48 538 512 756","email":"vendors.clinical@ryvu.com","created_by":null,"created_at":"2025-07-31 13:43:16","modified_at":"2025-07-31 13:43:16","modified_by":null}],"orders":[{"id":331471,"estimated_value":null,"order_items":[{"id":376030,"description":"In connection with the implementation of project titled \"Clinical development of an innovative drug candidate in solid tumors\" (co-financing agreement number: POIR.01.01.01-00-1386/20), co-financed by the European Regional Development Fund under Smart Growth Operational Programme 2014-2020, and in connection with the obligation to make purchases based on the most economically advantageous offer, while maintaining the principles of fair competition, efficiency, openness and transparency, Ryvu Therapeutics S.A. submits an inquiry regarding the support of the RVU120 Investigational Medicinal Product management (packing, storage, supply, status monitoring, return, and destruction) in the phase II study of RVU120 in patients with Relapse/ Refractory Metastatic or Advanced Solid Tumors. A detailed description of the subject of the order can be found in section II. of this RFP.\n\nA detailed description of the subject of the order can be found in section II. of this RFP.","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-03-31 13:19:49","modified_at":"2023-03-31 13:19:49","modified_by":null,"id":423529,"type":{"id":1,"name":"adres"},"group_uuid":"8503318a-b041-4914-ac5e-6446de1026ae"}],"participation_conditions":[{"id":1023388,"description":"Requirements for the contractor\nTenderers need to confirm they have the required country-specific regulatory agency license/permit required for storage, packaging/labelling, release for clinical use, distribution, import from third countries, destruction of investigational medicinal products, documents confirming of having passed the current audits, documented experience in managing investigational drug, including appropriate storage conditions with monitoring and accounting system.\nThe Ordering Party reserves the right to view the documents given above.\nThe above conditions should be confirmed by a statement \u2013 Appendix 1 to this Request for Quotation.\nTenderers, who are related by capital or personally to the Ordering Party (mutual relations between the Ordering Party or persons authorized to incur liabilities on behalf of the Ordering Party or persons performing activities related to the execution of the selection procedure on behalf of the Ordering Party and the Tenderer), shall be excluded from competing for the contract \u2013 the condition to be confirmed by a statement.\nCapital or personal links shall mean mutual links between the Ordering Party or persons authorized to incur liabilities on behalf of the Ordering Party or persons carrying out activities connected with the preparation and execution of the selection procedure on behalf of the Ordering Party and the Economic Operator, consisting in particular in:\n\u2212 participation in the company as a partner in a civil or other personal partnership;\n\u2212 holding at least 10% of shares or stocks;\n\u2212 acting as a member of a supervisory or managerial body, proxy, attorney;\n\u2212 being married, in a relationship of kinship or affinity in a straight line, kinship of the second degree or affinity of the second degree in a collateral line, or in a relationship of adoption, custody or guardianship.\nNon-existence of such links must be confirmed by the statement \u2013 Appendix 1 to this Request for Proposal.\n\nEligible to compete for a contract shall be Bidders who:\n\u2212 has formal qualifications to perform specific activity or actions, if such qualifications are required by the law.\n\u2212 is engaged in activities consistent with the description of the subject-matter of the contract.\n\u2212 has the necessary knowledge and experience and has at its disposal the technical potential and personnel capable of performing the contract.\n\u2212 is in an economic and financial condition ensuring the performance of the contract.\n\u2212 is not in liquidation or has not been declared bankrupt.\n\u2212 is not in arrears with payment of public and legal charges, taxes or social or health insurance contributions.\nThe above conditions should be confirmed by a statement \u2013 Appendix 1 to this Request for Quotation.\n\nTenderers, who are not subject to exclusion on the basis of Article 7(1) of the Act of 13 April 2022 on Special Measures to Counteract the Support of Aggression Against Ukraine and to Protect National Security (Journal of Laws item 835), may compete for the contract.\nLack of grounds for exclusion on the above-mentioned legal basis should be confirmed by a statement \u2013 Appendix 1 to this Request for Quotation.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-03-31 13:19:49","modified_at":"2023-03-31 13:19:49","modified_by":null,"group_uuid":"18f0945d-3312-41e4-9b75-4d00c45dd1b0"},{"id":1023389,"description":"Uzupe\u0142niony Za\u0142\u0105cznik 1 (Appendix 1)","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2023-03-31 13:19:49","modified_at":"2023-03-31 13:19:49","modified_by":null,"group_uuid":"c9cbd147-2700-4cb4-a49b-161d8397f704"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-03-31 13:19:49","modified_at":"2023-03-31 13:19:49","modified_by":null,"group_uuid":"0bb73951-5207-4b3e-bd74-76ef6a791fe6"}],"evaluation_criteria":[{"id":575830,"price_criterion":true,"description":"Net price (\"C\") \u2013 weight: 100% (10 points)\nNet price (\"C\") is considered as total price of Investigational Medicinal Product management together with all additional costs necessary to perform the study (direct, indirect and pass-through costs).\nThe Offer must include prices given in EUR.","created_by":null,"created_at":"2023-03-31 13:19:49","modified_at":"2023-03-31 13:19:49","modified_by":null,"group_uuid":"fcc6c941-9afd-4cd1-b84a-ddc00c3e37f4"}],"is_variant":false,"title":"Cz\u0119\u015b\u0107 1","order_node":{"id":252357},"created_by":null,"created_at":"2023-03-31 13:19:49","modified_at":"2023-03-31 13:19:49","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":521387,"street":"Leona Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2023-03-31 13:19:49","modified_at":"2023-03-31 13:19:49","modified_by":{"id":112,"contact_persons":[]},"id":200844},"advertisement":{"id":152991,"number":"2023-112-152991","publication_date":"2023-03-31","created_by":{"id":112,"contact_persons":[]},"created_at":"2023-03-31 13:19:49","modified_at":"2023-05-03 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[200390],"enrollment":null,"projects":[{"id":15193,"name":"Rozw\u00f3j kliniczny innowacyjnego kandydata na lek w terapii nowotwor\u00f3w litych","number":"1386/20","activity":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"region":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2022-02-10 21:45:42","modified_at":"2022-02-10 21:45:42","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"institution":null,"full_number":"POIR.01.01.01-00-1386/20","perspective":{},"programme":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"type":"project","created_by":{"id":112,"contact_persons":[]},"created_at":"2021-03-19 10:38:46","modified_at":"2021-03-19 10:38:46","modified_by":{"id":112,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":200390,"publication_date":"2023-03-31"},"id":960988,"name":"RPF 31 03 2023 IMP","file":{"id":1071219,"name":"RFP 31 03 2023 IMP.pdf","created_at":"2023-03-31 13:17:28","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1071219"},"group_uuid":"3a199229-15fd-4e53-9d94-ba8e57776a8c"},{"origin":{"id":200390,"publication_date":"2023-03-31"},"id":960989,"name":"Za\u0142\u0105cznik 1 (Appendix 1)","file":{"id":1071222,"name":"Appendix 1 to RFP 31 03 2023 IMP.docx","created_at":"2023-03-31 13:17:54","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1071222"},"group_uuid":"da328520-575a-467f-85a4-f9032d21d898"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}